Drug
tocilizumab-aazg
Marketed as TYENNE.
Generic name
tocilizumab-aazg
Brand names
TYENNE
First FDA approval
2024-03-05
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761449 | TYENNE | 2025-03-14 | FRESENIUS KABI USA |
| BLA761275 | TYENNE | 2024-03-05 | FRESENIUS KABI USA |
Manufacturers
FRESENIUS KABI USA
Frequently asked questions
When was tocilizumab-aazg FDA approved?
Earliest FDA approval on record: 2024-03-05.
What brand names are sold as tocilizumab-aazg?
TYENNE.
Sources
Appeal a tocilizumab-aazg denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com